Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 1999 April;40(2) > The Journal of Cardiovascular Surgery 1999 April;40(2):227-8

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE JOURNAL OF CARDIOVASCULAR SURGERY

Rivista di Chirurgia Cardiaca, Vascolare e Toracica


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

CASE REPORTS  CARDIAC PAPERS


The Journal of Cardiovascular Surgery 1999 April;40(2):227-8

Copyright © 2000 EDIZIONI MINERVA MEDICA

lingua: Inglese

Perioperative management of a patient with Werlhof disease undergoing myocardial revascularization

Gaudino M., Luciani N., Piancone F. L., Bruno P., Rossi M., Schiavello R., Possati G.

From the Department of Cardiac Surgery and * Anaesthesiology Catholic University, Rome, Italy


PDF  


We ­herein ­report the ­case of a ­patient ­with ­idiopathic throm­bo­cy­to­penic pur­pura (­Werlhof dis­ease) and cor­o­nary ­artery dis­ease under­going myo­car­dial revas­cu­lar­iza­tion. The use of mono­meric immu­no­glob­u­lins, cor­ti­cos­ter­oids, plate­lets trans­fu­sion, use of a ­cell ­saver, nor­mo­thermic car­di­o­pul­mo­nary ­bypass, aprot­i­nine and homol­o­gous ­blood trans­fu­sion ­were com­bined in ­order to min­i­mize the ­risk of ­bleeding com­pli­ca­tions in the post­op­er­a­tive ­period.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail